Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 11, 2012, Pages 1859-1871

  Molnar, Miklos Z ^b   Kovesdy, Csaba P ^b   Mucsi, Istvan ^b   Salusky, Isidro B ^b   Kalantar Zadeh, Kamyar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCIUM; PARATHYROID HORMONE;

ACUTE GRAFT REJECTION; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DISEASE; CALCIUM BLOOD LEVEL; CAUSE OF DEATH; COHORT ANALYSIS; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEMODIALYSIS PATIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MINERAL AND BONE DISORDER; MORTALITY; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

ADULT; BIOLOGICAL MARKERS; BONE DISEASES; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MINERALS; TREATMENT OUTCOME;

EID: 84869122620     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01910212     Document Type: Article

References (30)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
2. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of alteredmineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67: 1179-1187, 2005
3. Slinin Y, Foley RN, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16: 1788-1793, 2005
4. Lukowsky LR, Molnar MZ, Zaritsky JJ, Sim JJ, Mucsi I, Kovesdy CP, Kalantar-Zadeh K: Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant 27: 2899-2907, 2012
5. Shantouf R, Kovesdy CP, Kim Y, Ahmadi N, Luna A, Luna C, Rambod M, Nissenson AR, Budoff MJ, Kalantar-Zadeh K: Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol 4: 1106-1114, 2009
6. Shoji T, Maekawa K, Emoto M, Okuno S, Yamakawa T, Ishimura E, Inaba M, Nishizawa Y: Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients. Atherosclerosis 210: 145-149, 2010
7. Raggi P, Giachelli C, Bellasi A: Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis. Nat Clin Pract Cardiovasc Med 4: 26-33, 2007
8. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, VanWyck D, Kopple JD, Kalantar-Zadeh K: Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19: 2193-2203, 2008
9. Rostand SG, Drüeke TB: Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56: 383-392, 1999
10. Hörl WH: The clinical consequences of secondary hyperparathyroidism: Focus on clinical outcomes. Nephrol Dial Transplant 19[Suppl 5]: V2-V8, 2004
11. Howard RJ, Patton PR, Reed AI, Hemming AW, Van der Werf WJ, Pfaff WW, Srinivas TR, Scornik JC: The changing causes of graft loss and death after kidney transplantation. Transplantation 73: 1923-1928, 2002
12. Sampaio MS, Molnar MZ, Kovesdy CP, Mehrotra R, Mucsi I, Sim JJ, Krishnan M, Nissenson AR, Kalantar-Zadeh K: Association of pretransplant serum phosphorus with posttransplant outcomes. Clin J Am Soc Nephrol 6: 2712-2721, 2011
13. Roodnat JI, van Gurp EA, Mulder PG, van Gelder T, de Rijke YB, de Herder WW, Kal-van Gestel JA, Pols HA, Ijzermans JN, Weimar W: High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation. Transplantation 82: 362-367, 2006
14. Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A: Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 5: 1934-1941, 2005
15. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP: Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation 87: 1040-1044, 2009
16. Ahmadi F, Ali-Madadi A, Lessan-Pezeshki M, Khatami M, Mahdavi-Mazdeh M, Razeghi E, Maziar S, Seifi S, Abbasi M: Pretransplant calcium-phosphate-parathormone homeostasis as a risk factor for early graft dysfunction. Saudi J Kidney Dis Transpl 19: 54-58, 2008
17. Boom H, Mallat MJ, de Fijter JW, Paul LC, Bruijn JA, van Es LA: Calcium levels as a risk factor for delayed graft function. Transplantation 77: 868-873, 2004
18. Krüger B, Schnitzbauer AA, Böger CA, Hoffmann U, Banas B, Farkas S, Schlitt HJ, Obed A, Krämer BK: Pretransplant calciumlevels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation. Transplant Proc 38: 697-700, 2006
19. Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S, Streja E, Krishnan M, Kalantar-Zadeh K: Higher recipient bodymass index is associated with post-transplant delayed kidney graft function. Kidney Int 80: 218-224, 2011
20. Molnar MZ, Kovesdy CP, Bunnapradist S, Streja E, Mehrotra R, Krishnan M, Nissenson AR, Kalantar-Zadeh K: Associations of pretransplant serum albumin with post-transplant outcomes in kidney transplant recipients. Am J Transplant 11: 1006-1015, 2011
21. Streja E, Molnar MZ, Kovesdy CP, Bunnapradist S, Jing J, Nissenson AR, Mucsi I, Danovitch GM, Kalantar-Zadeh K: Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol 6: 1463-1473, 2011
22. Molnar MZ, Huang E, Hoshino J, Krishnan M, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K: Association of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients. Diabetes Care 34: 2536-2541, 2011
23. Molnar MZ, Mehrotra R, Duong U, Bunnapradist S, Lukowsky LR, Krishnan M, Kovesdy CP, Kalantar-Zadeh K: Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol 7: 332-341, 2012
24. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT Jr, Segre GV: Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33: 1364-1367, 1987
25. Yarlagadda SG, Coca SG, Garg AX, Doshi M, Poggio E, Marcus RJ, Parikh CR: Marked variation in the definition and diagnosis of delayed graft function: A systematic review. Nephrol Dial Transplant 23: 2995-3003, 2008
26. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K: Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88: 1511-1518, 2008
27. Kovesdy CP, Kalantar-Zadeh K: Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int 73: 1355-1363, 2008
28. Hill AB: The environment and disease: Association or causation? Proc R Soc Med 58: 295-300, 1965
29. Kalantar-Zadeh K: What is so bad about reverse epidemiology anyway? Semin Dial 20: 593-601, 2007
30. Deluca HF, Cantorna MT: Vitamin D: Its role and uses in immunology. FASEB J 15: 2579-2585, 2001